If someone tries to convince you to buy a stock they usually have a personal agenda to do so. Not because they are concerned about you making money but about convincing you to buy so they can make money. Same is true for those yelling sell.
Recent CRVS News
- Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis • GlobeNewswire Inc. • 04/09/2024 08:01:00 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/19/2024 08:02:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024 • GlobeNewswire Inc. • 03/13/2024 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:57:04 PM
- Corvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseases • GlobeNewswire Inc. • 02/12/2024 01:30:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:27:12 PM
- Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma • GlobeNewswire Inc. • 02/08/2024 09:05:00 PM
- Corvus Pharmaceuticals Appoints Jeffrey Arcara as Chief Business Officer • GlobeNewswire Inc. • 02/06/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:00:15 PM
- Corvus Pharmaceuticals Announces the Passing of Board Member Edith P. Mitchell • GlobeNewswire Inc. • 01/23/2024 10:00:00 PM
- Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial • GlobeNewswire Inc. • 12/09/2023 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:07:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:03:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:03:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:02:38 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/07/2023 09:01:00 PM
- Corvus Pharmaceuticals to Present New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition • GlobeNewswire Inc. • 11/02/2023 01:15:00 PM
- Corvus Pharmaceuticals Announces Publication of Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to T Cell-Mediated Inflammatory and Immune Diseases • GlobeNewswire Inc. • 11/01/2023 11:31:53 PM
- Corvus Pharmaceuticals to Provide Business Update and Report Third Quarter Financial Results on November 7, 2023 • GlobeNewswire Inc. • 10/31/2023 08:02:00 PM
- Corvus Pharmaceuticals Confirms Planned Initiation of Soquelitinib (CPI-818) Phase 3 Registrational Clinical Trial in Peripheral T Cell Lymphoma Following Meeting with FDA • GlobeNewswire Inc. • 09/06/2023 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:02:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:01:11 PM
- Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results • GlobeNewswire Inc. • 08/08/2023 08:01:00 PM
- Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter Financial Results on August 8, 2023 • GlobeNewswire Inc. • 08/01/2023 12:30:00 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM